Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00068211

Locations


United States, Arizona
	Arizona Cancer Center at Scottsdale
	Scottsdale, Arizona, United States, 85285
	Univ of Arizona Cancer Center
	Tucson, Arizona, United States, 85724

United States, California
	Cancer Institute Medical Group
	Santa Monica, California, United States, 90404
	USC / Norris Cancer Center
	Los Angeles, California, United States, 90033

United States, Colorado
	Univ of Colorado Cancer Center/ Anschutz Cancer
	Aurora, Colorado, United States, 80010

United States, Florida
	US Oncology / Cancer Centers of Florida
	Orlando, Florida, United States, 32806

United States, Kansas
	US Oncology / Kansas City Oncology
	Overland Park, Kansas, United States, 66210

United States, Massachusetts
	Beth Israel Medical Center
	Boston, Massachusetts, United States, 02215

United States, Missouri
	US Oncology / Kansas City Oncology and Hematology
	Kansas City, Missouri, United States, 64111
	Center for Cancer Care Research
	St. Louis, Missouri, United States, 63141

United States, New York
	US Oncology / Albany Regional Cancer Center
	Albany, New York, United States, 12208

United States, Ohio
	US Oncology / Dayton Oncology and Hematology
	Kettering, Ohio, United States, 45409

United States, South Carolina
	US Oncology / Cancer Centers of the Carolinas
	Greenville, South Carolina, United States, 29615

United States, Texas
	St. Luke's Episcopal Hospital
	Houston, Texas, United States, 77030
	US Oncology / Mary Crowley Medical Research
	Dallas, Texas, United States, 75246
	US Oncology/ Tyler Cancer Center
	Tyler, Texas, United States, 75702
	US Oncology /Texas Oncology
	Ft. Worth, Texas, United States, 76104

United States, Washington
	Seattle Cancer Care Alliance
	Seattle, Washington, United States, 98109
	US Oncology / Cancer Care Northwest
	Spokane, Washington, United States, 99218

Sponsors and Collaborators

Genzyme